Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193632 | SCV000249304 | pathogenic | Complex cortical dysplasia with other brain malformations 5 | 2015-04-24 | criteria provided, single submitter | clinical testing | |
UCLA Clinical Genomics Center, |
RCV000193632 | SCV000255500 | likely pathogenic | Complex cortical dysplasia with other brain malformations 5 | 2014-04-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001563629 | SCV001786607 | pathogenic | TUBB2A-related tubulinopathy | 2020-12-09 | criteria provided, single submitter | clinical testing | The TUBB2A c.1033A>T (p.Ile345Phe) variant is a missense variant that has been identified in a de novo heterozygous state in an individual with developmental delay, epilepsy, seizures, infantile spasms, perisylvian polymicrogyria, microcephaly and plagiocephaly (Lee et al. 2014). The p.Ile345Phe variant is not found in the Genome Aggregation Database in a region of reasonably good sequence coverage, suggesting that it is a rare variant. Additionally, it is located in a C-terminal domain of the TUBB2A gene that is important for protein interaction (Cai et al. 2020) and in silico tools predict damaging effect of the variant on the protein. Based on the collective evidence and application of the ACMG criteria, the p.Ile345Phe variant is classified as pathogenic for TUBB2A-related tubulinopathy. |